Guaianolide sesquiterpene natural products are of great biological and synthetic importance.
Among them, phaeocaulisin A with a unique tetracyclic skeleton was isolated in 2013
and found to exhibit anticancer cell proliferation activity and anti-inflammatory
activity. The first total synthesis of (-)-phaeocaulisin A was achieved by Procter
and co-workers in 2022. Two years later, we reported a total synthesis of (±)-phaeocaulisin
A. The key steps of our total synthesis include a novel palladium-catalyzed cyclopropanol
ring-opening carbonylative esterification to access a key γ-ketoester, a regio- and
stereo-selective aldol cyclization to build the 7-membered carbocycle, and a cascade
ketalization/lactonization to construct the tetracyclic skeleton. This Synpact article
reflects our journey toward (±)-phaeocaulisin A, which also led to the discovery of
an analog with potent anticancer activity against triple negative or HER2+ breast
cancer.